Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Revenue

Repare Therapeutics had revenue of $1.07M in the twelve months ending March 31, 2025, down -98.90% year-over-year. In the year 2024, Repare Therapeutics had annual revenue of $53.48M with 4.58% growth.

• Revenue (ttm): $1.07M
• Revenue Growth: -98.90%
• P/S Ratio: 55.85
• Revenue / Employee: $8,318
• Employees: 129
• Market Cap: 60.48M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	53.48M	2.34M	4.58%
Dec 31, 2023	51.13M	-80.70M	-61.21%
Dec 31, 2022	131.83M	124.23M	1,634.61%
Dec 31, 2021	7.60M	7.47M	5,529.63%
Dec 31, 2020	135.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.